In Depth 30 Oct 2024
Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?
Discover how next-generation “switchable” CAR-T cells could improve both the safety and efficacy of CAR-T therapies.
Immunotherapy
- Latest Posts
In Depth 18 Sep 2024
Two targets, one solution: The rise of bispecific antibodies
Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape looks like.
News and Trends 16 Sep 2024
Vironexis’ AAV vector approach: The next frontier in cancer immunology?
Delve into Vironexis’ launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.
News and Trends 4 Sep 2024
2024: a year of breakthroughs for endometrial cancer?
New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs.
News and Trends 16 Jul 2024
German biotech raises $150M on its way to tackle cancer therapy resistance
On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round.
In Depth 5 Jun 2024
Evolving standards of care: new treatments for cervical cancer
New treatments for cervical cancer aim to broaden therapeutic options, and improve current standards of care for patients.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 28 May 2024
8 Swedish companies spearheading the country’s biotech scene
As Sweden’s life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry.
Best in Biotech 21 May 2024
Eight companies spearheading Philadelphia’s biotech industry
Often called the Cellicon Valley due to its focus on cell and gene therapy, discover eight Philadelphia biotech companies to know about.
In Depth 24 Apr 2024
Overcoming toxicities: are IL-2 smart cytokines the next big thing?
A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it.
Best in Biotech 14 Mar 2024
7 oncolytic virus companies you should know about
Find out more about 7 oncolytic virus companies advancing their drug candidates through clinical trials to help cancer patients.
In Depth 5 Feb 2024
Future of cancer treatment: what will therapy look like in 2034?
From groundbreaking immunotherapies to AI diagnostics and new vaccines, explore the innovations shaping the future of cancer treatment.
Best in Biotech 30 Jan 2024
Navigating German biotech: 13 key players to know
The German biotech ecosystem is well established despite the challenges it is facing. Discover thirteen key Germany-based biotech companies.
ADVERTISEMENT
